Valar Labs has announced the successful completion of a $22 million Series A funding round, co-led by DCVC and a16z, with participation from Pear VC. The biotech startup has developed an AI-powered diagnostic tool, Vesta, which predicts treatment responses for bladder cancer patients. This tool, based on computational histology, aims to reduce uncertainty in cancer treatment decisions and is already in commercial use for bladder cancer. Valar Labs plans to expand its application to other types of cancer. The technology has been highlighted in a Nature story, and the company aims to translate this tech to clinical settings, potentially saving precious time for patients. There are roughly 2 million new cancer diagnoses annually in the US alone.
Valar Labs, which has developed AI models to help predict bladder cancer treatment outcomes, raised a $22M Series A led by DCVC and a16z (Devin Coldewey / TechCrunch) https://t.co/N0uHyZegwr 📫 Subscribe: https://t.co/OyWeKSRpIM https://t.co/mvSKT4fnKL
We @a16z are thrilled to announce our Series A investment in @valarlabs, which is building AI tools to assist oncologists in cancer treatment decisions. There are roughly 2 million new cancer diagnoses annually in the US alone. Each diagnosis involves a biopsy of the patient's… https://t.co/xeQ5zTTOpQ
Excited to announce @DCVC’s investment in @valarlabs Valar’s “computational histology” platform provides prognosis and tx response prediction for cancer patients Already commercial in bladder cancer, excited to see this team expand to new indications! https://t.co/Fiwgpd1ALO
Thrilled to announce Valar Labs' $22 million Series A co-led by @DCVC and @a16z with participation from @pearvc ! https://t.co/lp10Mn8O7x We founded Valar Labs to reduce uncertainty in cancer treatment decisions for patients and providers. Over the last 3 years we have…
Valar Labs debuts AI-powered cancer care prediction tool and secures $22M: https://t.co/25CEun0nwm by TechCrunch #infosec #cybersecurity #technology #news
Valar Labs Announces $22 Million Series A to Advance Vesta, First AI Diagnostic Test to Predict Treatment Response in Bladder Cancer, and Catalyze Expansion in Other Cancers https://t.co/lIP1OOWvky
Valar Labs debuts AI-powered cancer care prediction tool and secures $22M: Biotech startup Valar Labs has built a tool that accurately predicts certain treatment outcomes, potentially saving precious time for patients. © 2024… https://t.co/SCve2MlXgk #AI #AInews #AItips
Valar Labs debuts AI-powered cancer care prediction tool and secures $22M https://t.co/KUIoVkMYzF
Hugely honored to be featured in @Nature story "AI assistance for planning cancer treatment". Thanks to @eisensteinm for covering our work on #AI for predicting response to IO. @PictureHealthAI is translating this tech to clinic. Learn more @ASCO https://t.co/ZKBf8vj1bh